Summary
The characteristic EPR doublet of tyrosine radicals of the growth-regulating enzyme ribonucleotide reductase was detected in human melanoma tissue grown in nude mice. This was possible through the use of an amelanotic melanoma that does not exhibit disturbing EPR signals from melanin. The content of tyrosine radicals is higher in young tumor tissues than in older ones. The clinically applied antimelanotic drug, 4-hydroxyanisole, inhibits ribonucleotide reductase in Ehrlich ascites tumor cells as demonstrated by a pronounced quenching of tyrosine radicals (IC50=5 μM). In amelanotic melanoma tissue tyrosine radicals of the enzyme are also quenched by 4-hydroxyanisole in concentrations down to 50 μM. Thus, the inactivation of ribonucleotide reductase, which provides deoxyribonucleotides for DNA synthesis, may be a hitherto unexpected mechanism for the antitumor action of 4-hydroxyanisole.
Similar content being viewed by others
Abbreviations
- EPR:
-
electron paramagnetic resonance
- RR:
-
ribonucleotide reductase
- 4-HA:
-
4-hydroxyanisole
References
Arnold W (1988) Tumormodelle zur in vivo —Charakterisierung antineoplastischer Pharmaka. Dissertation B, Akademie der Wissenschaften
Cory JG, Cory AH (1989) Inhibitors of ribonucleotide diphosphate reductases activity. Pergamon Press, New York
Dewey DL, Butcher FW, Galpine AR (1977) Hydroxyanisole-induced regression of the Harding-Passey melanoma in mice. J Pathol 122:117–127
Elford HL (1984) The effect of hydroxyanisole on mammalian ribonucleotide reductase. In: Riley PA (ed) Hydroxyanisole, recent advances in antimelanoma therapy. IRL, Oxford, pp 71–76
Eriksson S, Graeslund A, Skog S, Thelander L, Tribukait B (1984) Cell cycle-dependent regulation of mammalian ribonucleotide reductase. The S phase-correlated increase in subunits M2 is regulated by de-novo protein synthesis. J Biol Chem 259:11695–11700
Fiedler H, Luebbe D, Wohlrab W, Wozniak KD, Taube HM, Hetschko I (1989) Die Ergebnisse der Chemotherapie des malignen Melanoms —5-Jahresanalyse einer prospektiven randomisierten Studie. In: Wosniak KD, Luebbe D (Hrsg) Wissenschaftliche Beiträge der Martin-Luther-Universität Halle-Wittenberg, S 158
Godzowa KW, Pultowa MU, Gorbachova LB (1987) Change of activity of ribonucleotide reductase of leukemic cells and spleen of mice in vivo during malignant growth and under influence of hydroxyurea. Dokl Acad Nauk USSR 297:480–482
Graeslund A, Ehrenberg A, Ehrenberg C (1983) Characterization of the free radical of mammalian ribonucleotide reductase. J Biol Chem 257:5711–5715
Graeslund A, Sahlin M, Sjoeberg BM (1985) The tyrosyl free radical in ribonucleotide reductase. Health Perspect 64:139–149
Lammers M, Follmann H (1983) The ribonucleotide reductases: a unique group of metalloenymes essential for cell proliferation. Struct Bonding 54:27–91
Lassmann G, Liermann B, Lehmann W, Graetz H, Koberling A, Langen P (1985) Ribonucleotide reductase in ascites tumor cells detected by electron paramagnetic resonance spectroscopy. Biochem Biophys Res Commun 132:1137–1143
Lassmann G, Liermann B, Langen P (1988) Stability and reactivation of tyrosine radicals from ribonucleotide reductase in tumor cells studies by ESR. Free Rad Biol Med 6:9–14
Lassmann G, Wessel R, Grasshoff P, Jakobs K, Schwarz D (1990) Einsatz des Arbeitsplatzrechners A 7100 zur Rationalisierung der Forschung in spektroskopischen Laboren. On-line-Kopplung am Beispiel von ESR-Spektrometern und Grafik-Software zur Erfassung bzw. Verarbeitung spektroskopischer Daten. Exp Techn Phys (im Druck)
Liermann B, Lassmann G, Langen P (1990) Quenching of tyrosine radicals of M2 subunit from ribonucleotide reductase in tumor cells by different antitumor agents. An EPR study. Free Rad Biol Med 9:1–4
Metcalf D (1984) Clonal culture of hemopoietic cells. Elsevier, New York
Morgan BDG, O'Neill TO, Dewey DL, Galpine AR, Riley PA (1981) Treatment of malignant melanoma by intravascular 4-hydroxyanisole. Clin Oncol 7:227–234
Neumeier R, Maurer HR (1980) Bovine lung conditioned medium as a source both human and murine colony-stimulating factor. Exp Hematol 8:728–736
Nilges MJ, Swartz HM, Riley PA (1984) Identification by ESR of free radicals formed during the oxidation of 4-hydroxyanisole catalyzed by tyrosinase. J Biol Chem 259:2446–2451
Pavel S, Holden JL, Riley PA (1989) Metabolism of 4-hydroxyanisole: identification of major urinary excretory products. Pigm Cell Res 2:421–426
Pulatowa MK, Richirewa GT, Kuroptewa (1989) EPR in molecular radiobiology (in Russian). Energoatomisdat, Moscow, p 92
Riley PA (1985) Radicals and melanomas. Philos Trans R Soc London [Biol] 311:679–689
Rubin EH, Cory JG (1986) Differential turnover of the subunits of ribonucleotide reductase in synchronized leukemia L 1210 cells. Cancer Res 46:6165–6168
Sjoeberg BM, Graeslund A (1983) Ribonucleotide reductase. Adv Inorg Biochem 5:87–110
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lassmann, G., Liermann, B., Arnold, W. et al. Ribonucleotide reductase in melanoma tissue. J Cancer Res Clin Oncol 117, 91–95 (1991). https://doi.org/10.1007/BF01613130
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01613130